Repurposing clinically approved cephalosporins for tuberculosis therapy-Reference-Cited by-同舟云学术

Repurposing clinically approved cephalosporins for tuberculosis therapy

Published:2016-09-28 Issue:1 Volume:6 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Ramón-García Santiago,González del Río Rubén,Villarejo Angel Santos,Sweet Gaye D.,Cunningham Fraser,Barros David,Ballell Lluís,Mendoza-Losana Alfonso,Ferrer-Bazaga Santiago,Thompson Charles J.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep34293.pdf

Reference57 articles.

1. Jassal, M. & Bishai, W. R. Extensively drug-resistant tuberculosis. Lancet Infect Dis 9, 19–30 (2009).

2. Payne, D. J., Gwynn, M. N., Holmes, D. J. & Pompliano, D. L. Drugs for bad bugs: confronting the challenges of antibacterial discovery. Nat Rev Drug Discov 6, 29–40 (2007).

3. New drug costs soar to $2.6 billion. Nat Biotech 32, 1176–1176 (2014).

4. Nguyen, L. & Thompson, C. J. Foundations of antibiotic resistance in bacterial physiology: the mycobacterial paradigm. Trends Microbiol 14, 304–312 (2006).

5. Ashburn, T. T. & Thor, K. B. Drug repositioning: identifying and developing new uses for existing drugs. Nat Rev Drug Discov 3, 673–683 (2004).

Cited by 68 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identification of Chemical Scaffolds That Inhibit the Mycobacterium tuberculosis Respiratory Complex Succinate Dehydrogenase;ACS Infectious Diseases;2024-09-13

2. Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal against Mycobacterium ulcerans;PLOS Neglected Tropical Diseases;2024-04-04

3. Amoxicillin/clavulanate in combination with rifampicin/clarithromycin is bactericidal againstMycobacterium ulcerans;2023-12-18

4. A dual-targeting succinate dehydrogenase and F1Fo-ATP synthase inhibitor rapidly sterilizes replicating and non-replicating Mycobacterium tuberculosis;Cell Chemical Biology;2023-12

5. In vitro bioevaluation and docking study of dihydrosphingosine and ethambutol analogues against sensitive and multi-drug resistant Mycobacterium tuberculosis;European Journal of Medicinal Chemistry;2023-10